A Phase I, Randomized, Placebo-Controlled, Crossover Clinical Trial to Assess the Safety of Oral SRT2104 and Its Effects on Vascular Dysfunction in Otherwise Healthy Cigarette Smokers and Subjects With Type 2 Diabetes Mellitus.
Phase of Trial: Phase I
Latest Information Update: 23 Jun 2017
At a glance
- Drugs SRT 2104 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Biomarker; Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 06 Jan 2012 Actual end date changed from Apr 2010 to May 2010 as reported by ClinicalTrials.gov.
- 28 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.